Characterization ofin vivoPharmacokinetic Properties of the Dopamine D1 Receptor Agonist DAR-0100A in Nonhuman Primates Using PET with [11C] NNC112 and [11C] Raclopride
Open Access
- 23 June 2010
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 31 (1) , 293-304
Abstract
DAR-0100A, the active enantiomer of dihydrexidine, is a potent dopamine D1 agonist under investigation for treatment of cognitive impairment and negative symptoms of schizophrenia. We measured the dose–occupancy relationship for DAR-0100A at D1 receptors using positron emission tomography (PET) imaging in baboons with [11C] NNC112 and its binding to D2 with [11C] raclopride. Two baboons were scanned with [11C] NNC112 at baseline and after three different doses of DAR-0100A. Two baboons were scanned with [11C] raclopride at baseline and after one dose of DAR-0100A. Occupancy (ΔBPND) was computed in the striatum and cortex. A clear relationship was observed between plasma concentration of DAR-0100A and ΔBPND. ΔBPNDwas larger in the striatum than in the cortex, consistent with reports showing that 25% of [11C] NNC112 BPNDin the cortex is attributed to 5-HT2A. Plasma EC50estimates ranged from 150 to 550 ng/mL according to the constraints on the model. There was no detectable effect of DAR-0100A on [11C] raclopride BPND. These data suggest that at doses likely to be administered to patients, occupancy will not be detectable with [11C] NNC112 PET and binding of DAR-0100A to D2 will be negligible. This is the first demonstration with PET of a significant occupancy by a full D1 agonist in vivo.Keywords
This publication has 38 references indexed in Scilit:
- Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging RadiotracersNeuropsychopharmacology, 2009
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding RadioligandsJournal of Cerebral Blood Flow & Metabolism, 2007
- A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophreniaSchizophrenia Research, 2007
- Agonist-Induced Cell Surface Trafficking of an Intracellularly Sequestered D1 Dopamine Receptor Homo-OligomerMolecular Pharmacology, 2006
- Differential Activation of Adenylate Cyclase and Receptor Internalization by Novel Dopamine D1 Receptor AgonistsMolecular Pharmacology, 2005
- Assessment of Dynamic Neurotransmitter Changes with Bolus or Infusion Delivery of Neuroreceptor LigandsJournal of Cerebral Blood Flow & Metabolism, 1998
- The Cubic Ternary Complex Receptor-Occupancy Model III. Resurrecting EfficacyJournal of Theoretical Biology, 1996
- The Cubic Ternary Complex Receptor–Occupancy Model II. Understanding Apparent AffinityJournal of Theoretical Biology, 1996
- The Cubic Ternary Complex Receptor–Occupancy Model I. Model DescriptionJournal of Theoretical Biology, 1996
- Dopaminergic Benzo[a]phenanthridines: Resolution and Pharmacological Evaluation of the Enantiomers of Dihydrexidine, the Full Efficacy D1 Dopamine Receptor AgonistJournal of Medicinal Chemistry, 1994